Abstinence symptoms during withdrawal from chronic marijuana use

Experimental and Clinical Psychopharmacology

Volumn 8, Issue 4, 2000, Pages 483-492

  Kouri, Elena M ^a   Pope Jr , Harrison G ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ABSTINENCE; ADULT; ANXIETY; APPETITE DISORDER; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG WITHDRAWAL; FEMALE; HUMAN; IRRITABILITY; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MOOD;

EID: 0033645788     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.8.4.483     Document Type: Article

References (42)

1. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A
2. Dependence on delta-9-tetrahydrocannabinol: Studies on precipitated and abrupt withdrawal
3. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey
4. Dependence on tetrahydrocannabinol in rhesus monkeys
5. College on problems of drug dependence meeting, Puerto Rico (June 1996): Marijuana use and dependence
6. Marijuana withdrawal among adults seeking treatment for marijuana dependence
7. Adults seeking treatment for marijuana dependence: A comparison with cocaine-dependent treatment seekers
8. Cannabis dependence and tolerance production
9. CB1 receptor antagonist precipitates withdrawal in mice exposed to delta-9-tetrahydrocannabinol
10. Physiological and psychological dependence to synthetic delta-9-tetrahydrocannabinol (THC) in rhesus monkeys
11. Mesolimbic dopaminergic decline after cannabinoid withdrawal
12. Case study: Withdrawal syndrome in adolescent chronic cannabis users
13. An abstinence syndrome following chronic administration of delta-9-tetrahydrocannabinol in rhesus monkeys
14. A rating scale for anxiety
15. A rating scale for depression
16. Abstinence symptoms following oral THC administration to humans
17. Abstinence symptoms following smoked marijuana in humans
18. Benzodiazepine-like behavioral effects following withdrawal from chronic delta-9-tetrahydrocannabinol administration in rats
19. Differentiating new marijuana use from residual drug excretion in occasional marijuana users
20. Detecting times of marijuana metabolites in urine by immunoassay and GC-MS
21. Urinary excretion profiles of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in humans after single smoked doses of marijuana
22. The 30-day trip: Clinical studies of cannabis tolerance and dependence
23. Clinical studies of cannabis tolerance and dependence
24. Clinical relevance of cannabis tolerance and dependence
25. Tolerance to and dependence on cannabis
26. Changes in aggressive behavior during withdrawal from long-term marijuana use
27. Operant acquisition of marijuana in man
28. Marijuana withdrawal syndrome in a woman
29. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor
30. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal
31. Withdrawal sequelae to cannabis use
32. Biopsychosocial changes associated with cessation of cannabis use: A single case study of acute and chronic cognitive effects, withdrawal and treatment
33. Adult marijuana users seeking treatment
34. Treating adult marijuana dependence: A test of the relapse prevention model
35. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1 opioid receptor mechanism
36. Time-course of the effects of chronic delta-9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behavior in the rat
37. The clinical syndrome of marijuana dependence
38. 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist
39. Attenuation of delta-9-tetrahydrocannabinol-induced withdrawal-like behaviour by delta-9-tetrahydrocannabinol
40. An evaluation of the history of a marijuana withdrawal syndrome in a large population